Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 206321

SAXENDA (LIRAGLUTIDE RECOMBINANT)
18MG/3ML (6MG/ML) Marketing Status: Prescription

Active Ingredient: LIRAGLUTIDE RECOMBINANT
Proprietary Name: SAXENDA
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 18MG/3ML (6MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206321
Product Number: 001
Approval Date: Dec 23, 2014
Applicant Holder Full Name: NOVO NORDISK INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English